KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Inventory (2016 - 2025)

Historic Inventory for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $6.3 billion.

  • Amgen's Inventory fell 1380.06% to $6.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 billion, marking a year-over-year decrease of 1380.06%. This contributed to the annual value of $7.0 billion for FY2024, which is 2647.62% down from last year.
  • According to the latest figures from Q3 2025, Amgen's Inventory is $6.3 billion, which was down 1380.06% from $6.6 billion recorded in Q2 2025.
  • Amgen's 5-year Inventory high stood at $9.5 billion for Q4 2023, and its period low was $4.0 billion during Q1 2021.
  • In the last 5 years, Amgen's Inventory had a median value of $5.0 billion in 2023 and averaged $5.8 billion.
  • Its Inventory has fluctuated over the past 5 years, first soared by 9306.29% in 2023, then crashed by 2647.62% in 2024.
  • Quarter analysis of 5 years shows Amgen's Inventory stood at $4.1 billion in 2021, then rose by 20.66% to $4.9 billion in 2022, then surged by 93.06% to $9.5 billion in 2023, then dropped by 26.48% to $7.0 billion in 2024, then decreased by 9.32% to $6.3 billion in 2025.
  • Its Inventory was $6.3 billion in Q3 2025, compared to $6.6 billion in Q2 2025 and $6.7 billion in Q1 2025.